INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,704 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
SE
Stevenson Trace EPresident, Autonomous Systems
AVAVAeroVironment Inc
Grant or award
A—
2,406 sh
Jul 2, 2026Jul 6, 2026
Page 580 of 1718
← PrevNext →
traded Jul 2, 2026
+4d
SEC Form 4

Evidence

17
MA
Marker Beth ASVP of Retail Operations
IPSTIP STRATEGY HOLDINGS, INC.
Option exercise
M—
94 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

17
PB
Perkins Danielle BSVP of Wholesale Operations
IPSTIP STRATEGY HOLDINGS, INC.
Option exercise
M—
94 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

16
KD
Knight Lea DanielsEVP & Chief Financial Officer
IARTINTEGRA LIFESCIENCES HOLDINGS CORP
Tax withholding
F$94K
5,226 sh
Jul 3, 2026Jul 6, 2026
traded Jul 3, 2026
+3dSEC Form 4

Evidence

16
RG
Renfroe Sean GGENERAL COUNSEL
TXRHTexas Roadhouse, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
426 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

15
BC
Blevins ChristopherGeneral Counsel
SBDSSolo Brands, Inc.
Option exercise
M—
12 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
DE
DeOliveira ErickChief Financial Officer
ZSPCzSpace, Inc.
Option exercise
M—
164 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
ND
Nikodemus Anton D.Chief Operating Officer
SNDASONIDA SENIOR LIVING, INC.
Grant or award
A—
12.1K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
MH
Malkani Dhiraj HCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Grant or award
A—
1,245 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
ND
Nikodemus Anton D.Chief Operating Officer
SNDASONIDA SENIOR LIVING, INC.
Grant or award
A—
75.0K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
SD
Stojanovic DanijelaInterim CFO
GEMIGemini Space Station, Inc.
Grant or award
A—
22.5K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
CT
Collins Michelle TDirector
ALBALBEMARLE CORP
Grant or award
A—
2 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
MB
Minor BradleyChief Marketing Officer
ETSYETSY INC
Option exercise
M—
859 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
OG
O'Brien Michael GrahamCFO
GTMZoomInfo Technologies Inc.
Option exercise
M—
1,555 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
GH
Germano Judith HDirector
DCOMDime Commercial Bancshares, Inc. /NY/
Grant or award
A$18K
439 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
KP
Kellenberger PaulDirector, Chief Executive Officer
ZSPCzSpace, Inc.
Option exercise
M—
2,680 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
BN
Bhagwakar Ranjana NEVP, Business Operations
ESABESAB Corp
Grant or award
A—
9,048 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
OW
Oman David WChief Risk Officer
TCBITEXAS CAPITAL BANCSHARES INC/TX
Option exercise
M—
2,748 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
DE
DeOliveira ErickChief Financial Officer
ZSPCzSpace, Inc.
Option exercise
M—
680 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
RD
Rome Marc D.SVP, Gen. Counsel & Corp. Sec.
CLWClearwater Paper Corp
Tax withholding
F$3,544
226 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$274K
6,080 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
VM
Vogt Adam MVP - Chief Accounting Officer
UFCSUNITED FIRE GROUP INC
Tax withholding
F$8,494
159 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
NN
Njoku NnamdiPresident & COO
OMCLOMNICELL, INC.
Grant or award
A—
12.3K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
DE
DeOliveira ErickChief Financial Officer
ZSPCzSpace, Inc.
Option exercise
M—
1,360 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
WT
Woodward Sean ThomasCFO
AVAVAeroVironment Inc
Grant or award
A$14K
97 sh
Jun 30, 2026Jul 6, 2026
traded Jun 30, 2026
+6dSEC Form 4

Evidence

15
MH
Malkani Dhiraj HCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Grant or award
A—
1,307 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
MB
Minor BradleyChief Marketing Officer
ETSYETSY INC
Option exercise
M—
4,441 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
CC
Cornelius CraigDirector, President & CEO
CWENClearway Energy, Inc.
Tax withholding
F—
7,184 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
BC
Blevins ChristopherGeneral Counsel
SBDSSolo Brands, Inc.
Tax withholding
F$17.3
5 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
CE
Colburn Richard Edward IIIChief Product & Tech Officer
ETSYETSY INC
Option exercise
M—
7,218 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
RJ
Reilly Jennifer JSVP and CHRO
HONHONEYWELL INTERNATIONAL INC
Grant or award
A—
669 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
MH
Malkani Dhiraj HCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Grant or award
A—
2,119 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$710K
2,600 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
HE
Harris Robert E.SVP & Chief Accounting Oficer
COLDAMERICOLD REALTY TRUST
Option exercise
M—
1,516 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
MH
Malkani Dhiraj HCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Grant or award
A—
14.0K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
LR
Lewis Michelle ReneeChief Accounting Officer
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$189K
4,200 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
BC
Blevins ChristopherGeneral Counsel
SBDSSolo Brands, Inc.
Option exercise
M—
12 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
CA
Chakravarthy ArthiChief Legal Officer
ENVXEnovix Corp
Tax withholding
F$20K
3,336 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
MH
Malkani Dhiraj HCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Grant or award
A—
2,188 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

15
BN
Bhagwakar Ranjana NEVP, Business Operations
ESABESAB Corp
Grant or award
A—
58.1K sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence